ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,331, issued on Feb. 24, was assigned to ORION Corp. (Espoo, Finland).
"Pregabalin formulations and use thereof" was invented by Mirja Huhtinen (Espoo, Finland), Terttu Lamminen (Espoo, Finland), Jukka Salmia (Espoo, Finland), Johanna Tervapuro (Espoo, Finland) and Jurgen Vercruysse (Zulte, Belgium).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a pharmaceutical composition in the form of an orally deliverable liquid composition comprising pregabalin as an active ingredient and to the use thereof in the treatment and prevention of transportation and veterinary visit anxiety and fear in companion animals, such as cats. The comp...